 |
BTG Gets 'Sentiment Boost' with Voraxaze Nod in U.S.
LONDON – BTG plc is celebrating its first regulatory approval after the FDA gave the nod to Voraxaze, an antidote to the chemotherapeutic methotrexate.
Customer Service: In the U.S. and Canada: 1-800-688-2421
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Thompson.com | Sheshunoff.com | ASPratt.com | AHCMedia.com | BioWorld.com | CMEweb.com | ThePerformanceInstitute.org | ASMIweb.com
Editorial Guidelines
For Site License Discounts, please contact Customer Service at (800) 688-2421 or customerservice@bioworld.com.